JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist

131
+2+1.55%

20min DelayMarket Closed May 31 15:00 JST

5.67BMarket Cap-4807P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Operating cash flow (Indirect Method)

Cash from operating activities

-728.14%-870.7M

86.47%-105.14M

-69.70%-776.84M

-457.78M

Net profit before non-cash adjustment

-193.49%-1.13B

51.53%-384.2M

-25.62%-792.62M

---630.97M

Total adjustment of non-cash items

40.08%352.28M

2,467.57%251.48M

-119.58%-10.62M

--54.26M

-Depreciation and amortization

----

--0

--12.81M

-Reversal of impairment losses recognized in profit and loss

----

--0

--26.36M

-Disposal profit

--0

----

-Net exchange gains and losses

109.56%440K

---4.6M

--0

----

-Other non-cash items

37.39%351.84M

2,510.88%256.08M

-170.40%-10.62M

--15.09M

Changes in working capital

-445.86%-95.39M

4.47%27.58M

-77.80%26.4M

--118.94M

-Change in receivables

-233.00%-70.54M

5,038.27%53.04M

-100.58%-1.07M

--185.59M

-Change in inventory

-5,034.59%-16.98M

-95.17%344K

171.05%7.12M

---10.02M

-Change in prepaid assets

90.80%-2.37M

-214.49%-25.8M

227.54%22.54M

---17.67M

-Change in payables

59.05%-3.46M

-131.36%-8.44M

280.07%26.91M

---14.95M

-Change in accrued expense

-100.47%-45K

250.09%9.62M

-53.06%2.75M

--5.85M

-Changes in other current assets

-70.36%-2M

96.31%-1.17M

-6.62%-31.84M

---29.86M

Dividends paid (cash flow from operating activities)

Dividends received (cash flow from operating activities)

Interest paid (cash flow from operating activities)

Interest received (cash flow from operating activities)

16.22%43K

27.59%37K

61.11%29K

18K

Tax refund paid

-0.67%-2.42M

-617.61%-2.4M

-100.21%-335K

157.11M

Other operating cash inflow (outflow)

-100.61%-2K

16,400.00%330K

0.00%2K

Operating cash flow

-714.62%-873.08M

86.21%-107.18M

-158.49%-777.14M

---300.65M

Investing cash flow

Net changes in other investments

---5.32M

----

---4.03M

----

Investing cash flow

---5.32M

--0

---4.03M

--0

Financing cash flow

Net common stock issuance

403.30%2.51B

-79.01%498.32M

138.24%2.37B

--996.35M

Issuance fees

-4,644.83%-594.95M

---12.54M

--0

----

Net other fund-raising expenses

----

--1.84M

----

Financing cash flow

292.34%1.91B

-79.46%487.62M

138.24%2.37B

--996.35M

Net cash flow

Beginning cash position

9.19%4.52B

62.50%4.14B

37.56%2.55B

--1.85B

Current changes in cash

171.97%1.03B

-76.11%380.44M

128.90%1.59B

--695.7M

End cash Position

22.89%5.56B

9.19%4.52B

62.50%4.14B

--2.55B

Free cash flow

-714.62%-873.08M

86.21%-107.18M

-158.49%-777.14M

---300.65M

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash from operating activities	-728.14%-870.7M	86.47%-105.14M	-69.70%-776.84M	-457.78M
Net profit before non-cash adjustment	-193.49%-1.13B	51.53%-384.2M	-25.62%-792.62M	---630.97M
Total adjustment of non-cash items	40.08%352.28M	2,467.57%251.48M	-119.58%-10.62M	--54.26M
-Depreciation and amortization	----	----	--0	--12.81M
-Reversal of impairment losses recognized in profit and loss	----	----	--0	--26.36M
-Disposal profit	--0	--0	--0	----
-Net exchange gains and losses	109.56%440K	---4.6M	--0	----
-Other non-cash items	37.39%351.84M	2,510.88%256.08M	-170.40%-10.62M	--15.09M
Changes in working capital	-445.86%-95.39M	4.47%27.58M	-77.80%26.4M	--118.94M
-Change in receivables	-233.00%-70.54M	5,038.27%53.04M	-100.58%-1.07M	--185.59M
-Change in inventory	-5,034.59%-16.98M	-95.17%344K	171.05%7.12M	---10.02M
-Change in prepaid assets	90.80%-2.37M	-214.49%-25.8M	227.54%22.54M	---17.67M
-Change in payables	59.05%-3.46M	-131.36%-8.44M	280.07%26.91M	---14.95M
-Change in accrued expense	-100.47%-45K	250.09%9.62M	-53.06%2.75M	--5.85M
-Changes in other current assets	-70.36%-2M	96.31%-1.17M	-6.62%-31.84M	---29.86M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)	16.22%43K	27.59%37K	61.11%29K	18K
Tax refund paid	-0.67%-2.42M	-617.61%-2.4M	-100.21%-335K	157.11M
Other operating cash inflow (outflow)	-100.61%-2K	16,400.00%330K	0.00%2K	2K
Operating cash flow	-714.62%-873.08M	86.21%-107.18M	-158.49%-777.14M	---300.65M
Investing cash flow
Net changes in other investments	---5.32M	----	---4.03M	----
Investing cash flow	---5.32M	--0	---4.03M	--0
Financing cash flow
Net common stock issuance	403.30%2.51B	-79.01%498.32M	138.24%2.37B	--996.35M
Issuance fees	-4,644.83%-594.95M	---12.54M	--0	----
Net other fund-raising expenses	----	--1.84M	----	----
Financing cash flow	292.34%1.91B	-79.46%487.62M	138.24%2.37B	--996.35M
Net cash flow
Beginning cash position	9.19%4.52B	62.50%4.14B	37.56%2.55B	--1.85B
Current changes in cash	171.97%1.03B	-76.11%380.44M	128.90%1.59B	--695.7M
End cash Position	22.89%5.56B	9.19%4.52B	62.50%4.14B	--2.55B
Free cash flow	-714.62%-873.08M	86.21%-107.18M	-158.49%-777.14M	---300.65M
Currency Unit	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall